Expression levels of cancer stem cell (CSC) marker genes Lgr5, Smoc2, Axin2, Rnf43, and CD44 were markedly reduced in Prrc2a‐deficient tumors induced by AOM‐DSS treatment (Figure 2A,B). This evidence concerns the gene PRRC2A and cancer.